252 related articles for article (PubMed ID: 16924474)
1. A CD40-CD95L fusion protein interferes with CD40L-induced prosurvival signaling and allows membrane CD40L-restricted activation of CD95.
Assohou-Luty C; Gerspach J; Siegmund D; Müller N; Huard B; Tiegs G; Pfizenmaier K; Wajant H
J Mol Med (Berl); 2006 Sep; 84(9):785-97. PubMed ID: 16924474
[TBL] [Abstract][Full Text] [Related]
2. CD40.FasL inhibits human T cells: evidence for an auto-inhibitory loop-back mechanism.
Dranitzki-Elhalel M; Huang JH; Sasson M; Rachmilewitz J; Parnas M; Tykocinski ML
Int Immunol; 2007 Apr; 19(4):355-63. PubMed ID: 17314083
[TBL] [Abstract][Full Text] [Related]
3. Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia.
Chu P; Deforce D; Pedersen IM; Kim Y; Kitada S; Reed JC; Kipps TJ
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3854-9. PubMed ID: 11891278
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway.
Ashany D; Savir A; Bhardwaj N; Elkon KB
J Immunol; 1999 Nov; 163(10):5303-11. PubMed ID: 10553053
[TBL] [Abstract][Full Text] [Related]
5. Resistance to CD95-mediated apoptosis of CD40-activated chronic lymphocytic leukemia B cells is not related to lack of DISC molecules expression.
de Totero D; Montera M; Rosso O; Clavio M; Balleari E; Foa R; Gobbi M
Hematol J; 2004; 5(2):152-60. PubMed ID: 15048066
[TBL] [Abstract][Full Text] [Related]
6. Death receptor-mediated apoptosis in human malignant glioma cells: modulation by the CD40/CD40L system.
Wischhusen J; Schneider D; Mittelbronn M; Meyermann R; Engelmann H; Jung G; Wiendl H; Weller M
J Neuroimmunol; 2005 May; 162(1-2):28-42. PubMed ID: 15833357
[TBL] [Abstract][Full Text] [Related]
7. CD40 activation-induced, Fas-dependent apoptosis and NF-kappaB/AP-1 signaling in human intrahepatic biliary epithelial cells.
Afford SC; Ahmed-Choudhury J; Randhawa S; Russell C; Youster J; Crosby HA; Eliopoulos A; Hubscher SG; Young LS; Adams DH
FASEB J; 2001 Nov; 15(13):2345-54. PubMed ID: 11689460
[TBL] [Abstract][Full Text] [Related]
8. Signaling active CD95 receptor molecules trigger co-translocation of inactive CD95 molecules into lipid rafts.
Lang I; Fick A; Schäfer V; Giner T; Siegmund D; Wajant H
J Biol Chem; 2012 Jul; 287(28):24026-42. PubMed ID: 22645131
[TBL] [Abstract][Full Text] [Related]
9. Expression and function of Fas antigen on activated murine B cells.
Wang J; Taniuchi I; Maekawa Y; Howard M; Cooper MD; Watanabe T
Eur J Immunol; 1996 Jan; 26(1):92-6. PubMed ID: 8566089
[TBL] [Abstract][Full Text] [Related]
10. Hetero-oligomerization between the TNF receptor superfamily members CD40, Fas and TRAILR2 modulate CD40 signalling.
Smulski CR; Decossas M; Chekkat N; Beyrath J; Willen L; Guichard G; Lorenzetti R; Rizzi M; Eibel H; Schneider P; Fournel S
Cell Death Dis; 2017 Feb; 8(2):e2601. PubMed ID: 28182009
[TBL] [Abstract][Full Text] [Related]
11. TWEAK inhibits TRAF2-mediated CD40 signaling by destabilization of CD40 signaling complexes.
Salzmann S; Lang I; Rosenthal A; Schäfer V; Weisenberger D; Carmona Arana JA; Trebing J; Siegmund D; Neumann M; Wajant H
J Immunol; 2013 Sep; 191(5):2308-18. PubMed ID: 23918987
[TBL] [Abstract][Full Text] [Related]
12. Improved immunogenicity of a self tumor antigen by covalent linkage to CD40 ligand.
Huang HI; Wu PY; Teo CY; Chen MN; Chen YC; Silin D; Tao MH
Int J Cancer; 2004 Feb; 108(5):696-703. PubMed ID: 14696096
[TBL] [Abstract][Full Text] [Related]
13. Promotion of activated human B cell apoptosis and inhibition of Ig production by soluble CD95 ligand: CD95-based downregulation of Ig production need not culminate in activated B cell death.
Stohl W; Xu D; Starling GC; Casali P; Kiener PA
Cell Immunol; 2000 Jul; 203(1):1-11. PubMed ID: 10915556
[TBL] [Abstract][Full Text] [Related]
14. Enforced covalent trimerization increases the activity of the TNF ligand family members TRAIL and CD95L.
Berg D; Lehne M; Müller N; Siegmund D; Münkel S; Sebald W; Pfizenmaier K; Wajant H
Cell Death Differ; 2007 Dec; 14(12):2021-34. PubMed ID: 17703232
[TBL] [Abstract][Full Text] [Related]
15. The role of CD40-CD40 ligand interactions in suppression of human B cell responsiveness by CD4+ T cells.
Hirohata S
Cell Immunol; 1997 Nov; 182(1):20-8. PubMed ID: 9427806
[TBL] [Abstract][Full Text] [Related]
16. Generation and Application of Bioluminescent CD95 Ligand Fusion Proteins.
Lang I; Kums J; Wajant H
Methods Mol Biol; 2017; 1557():63-77. PubMed ID: 28078583
[TBL] [Abstract][Full Text] [Related]
17. Enhanced therapeutic anti-tumor immunity induced by co-administration of 5-fluorouracil and adenovirus expressing CD40 ligand.
Liljenfeldt L; Gkirtzimanaki K; Vyrla D; Svensson E; Loskog AS; Eliopoulos AG
Cancer Immunol Immunother; 2014 Mar; 63(3):273-82. PubMed ID: 24357147
[TBL] [Abstract][Full Text] [Related]
18. Selective elimination of pathogenic synovial fluid T-cells from rheumatoid arthritis and juvenile idiopathic arthritis by targeted activation of Fas-apoptotic signaling.
Bremer E; Abdulahad WH; de Bruyn M; Samplonius DF; Kallenberg CG; Armbrust W; Brouwers E; Wajant H; Helfrich W
Immunol Lett; 2011 Aug; 138(2):161-8. PubMed ID: 21514322
[TBL] [Abstract][Full Text] [Related]
19. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells.
Hermisson M; Weller M
Cell Death Differ; 2003 Sep; 10(9):1078-89. PubMed ID: 12934082
[TBL] [Abstract][Full Text] [Related]
20. MHC class II and CD40 play opposing roles in dendritic cell survival.
McLellan A; Heldmann M; Terbeck G; Weih F; Linden C; Bröcker EB; Leverkus M; Kämpgen E
Eur J Immunol; 2000 Sep; 30(9):2612-9. PubMed ID: 11009095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
